knowledge
Previous article:
Continuity nursing helped my family in our darkest PICU moments
Next article: J&J to buy cancer drug developer Ambrx Biopharma
Next article: J&J to buy cancer drug developer Ambrx Biopharma
focus
focus
-
JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
2025-10-01 05:42 -
3 trends to watch in health tech's hiring outlook for 2024
2025-10-01 05:23 -
Why the world’s most expensive drug might be worth the price
2025-10-01 05:02 -
Readout Newsletter: WuXi and Congress, Boundless Bio, etc.
2025-10-01 05:00 -
Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more
2025-10-01 04:42 -
Insitro, AI biotech unicorn, brings cash, new research to JPM 2024
2025-10-01 04:11